Published in Am J Physiol Gastrointest Liver Physiol on June 12, 2014
Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring. Neurogastroenterol Motil (2016) 0.77
Acid sensitivity of the spinal dorsal root ganglia C-fiber nociceptors innervating the guinea pig esophagus. Neurogastroenterol Motil (2015) 0.76
Expert consensus document: Advances in the physiological assessment and diagnosis of GERD. Nat Rev Gastroenterol Hepatol (2017) 0.76
Impaired Esophageal Mucosal Integrity May Play a Causative Role in Patients With Nongastroesophageal Reflux Disease-Related Noncardiac Chest Pain. Medicine (Baltimore) (2015) 0.75
A weakly acidic solution containing deoxycholic acid induces esophageal epithelial apoptosis and impairs integrity in an in vivo perfusion rabbit model. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Esophageal Acid Clearance During Random Swallowing Is Faster in Patients with Barrett's Esophagus Than in Healthy Controls. J Neurogastroenterol Motil (2016) 0.75
Eosinophilic esophagitis: From pathophysiology to treatment. World J Gastrointest Pathophysiol (2015) 0.75
Emerging dilemmas in the diagnosis and management of gastroesophageal reflux disease. F1000Res (2017) 0.75
Reflux episodes and esophageal impedance levels in patients with typical and atypical symptoms of gastroesophageal reflux disease. Medicine (Baltimore) (2017) 0.75
Relationship Between Salivary Pepsin Concentration and Esophageal Mucosal Integrity in Patients With Gastroesophageal Reflux Disease. J Neurogastroenterol Motil (2017) 0.75
Histological Response to Fluticasone Propionate in Patients With Eosinophilic Esophagitis Is Associated With Improved Functional Esophageal Mucosal Integrity. Am J Gastroenterol (2015) 2.16
Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis. Clin Gastroenterol Hepatol (2014) 1.55
Liver function declines with increased age. HPB (Oxford) (2016) 0.80
Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies. Hepatology (2016) 0.80
Salsalate attenuates diet induced non-alcoholic steatohepatitis in mice by decreasing lipogenic and inflammatory processes. Br J Pharmacol (2015) 0.79
Esophageal and Small Intestinal Mucosal Integrity in Eosinophilic Esophagitis and Response to an Elemental Diet. Am J Gastroenterol (2017) 0.78
Evaluation of allergen-microarray-guided dietary intervention as treatment of eosinophilic esophagitis. J Allergy Clin Immunol (2015) 0.78
Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis. J Hepatol (2015) 0.76
Comparing 3 guidelines on the management of surgically removed pancreatic cysts with regard to pathological outcome. Gastrointest Endosc (2016) 0.76
Development of a Risk Score to Predict Detection of Metastasized or Locally Advanced Perihilar Cholangiocarcinoma at Staging Laparoscopy. Ann Surg Oncol (2016) 0.75
A cystic, septated lesion in the liver with unusual diagnosis. BMJ Case Rep (2014) 0.75
Knockout of the Primary Sclerosing Cholangitis-Risk Gene Fut2 Causes Liver Disease in Mice. Hepatology (2017) 0.75
Validation of the Prognostic Value of Histologic Scoring Systems in Primary Sclerosing Cholangitis; An International Cohort Study. Hepatology (2016) 0.75
Future remnant liver function as predictive factor for the hypertrophy response after portal vein embolization. Surgery (2017) 0.75
Genomic characterization of malignant progression in neoplastic pancreatic cysts. Nat Commun (2020) 0.75
Human intrahepatic CD69 + CD8+ T cells have a tissue resident memory T cell phenotype with reduced cytolytic capacity. Sci Rep (2017) 0.75
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis. Gut (2017) 0.75